{"entity":{"id":"institut-curie","kind":"institution","name":"Institut Curie","aka":[],"tldr":"Founded by Marie Curie; a leader in breast cancer, radiotherapy, and proton therapy.","summary":"Institut Curie in Paris was founded by Marie Curie and is a comprehensive cancer centre and research institute, ranked twenty-first in the Newsweek/Statista World's Best Specialized Hospitals list for oncology. Its strengths are breast cancer and the biology of triple-negative disease, radiotherapy and the Orsay proton centre, uveal melanoma and paediatric oncology, with François-Clément Bidard, Olivier Delattre, Christophe Le Tourneau, Eliane Piaggio and Sergio Roman-Roman among its scientists. OnCo links it to the tumour microenvironment pathway, to the question of what holds T cells at the tumour border, and to Institut National du Cancer, Fondation ARC and the LYSA lymphoma group. How to turn microenvironment biology into treatments is the problem its immunology work chases. Its breast and proton programmes are the ones most readers want.","asOf":"2026-09-04","links":[{"label":"Official website","url":"https://curie.fr"},{"label":"PTCOG: particle therapy facilities in operation","url":"https://www.ptcog.site/index.php/facilities-in-operation-public"}],"tags":[],"related":[],"cancers":["tnbc","melanoma"],"sections":[],"technologies":["proton-therapy","proton-therapy-systems"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":["francois-clement-bidard","sergio-roman-roman","eliane-piaggio","olivier-delattre","steven-le-gouill"],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"Paris","country":"FR","lat":48.844,"lng":2.344,"institutionType":"cancer-center","website":"https://curie.fr","newsweekOncology2026":21,"programs":["Breast cancer","Proton therapy","Uveal melanoma"]},"route":"/institutions/institut-curie/","neighbours":{"cancer":[{"id":"melanoma","kind":"cancer","name":"Melanoma","route":"/cancers/melanoma/"},{"id":"tnbc","kind":"cancer","name":"Triple-negative breast cancer (TNBC)","route":"/cancers/tnbc/"}],"technology":[{"id":"proton-therapy","kind":"technology","name":"Proton therapy","route":"/technologies/proton-therapy/"},{"id":"proton-therapy-systems","kind":"technology","name":"Proton therapy machines: cyclotrons, synchrotrons and single-room systems","route":"/technologies/proton-therapy-systems/"}],"person":[{"id":"christophe-le-tourneau","kind":"person","name":"Christophe Le Tourneau","route":"/people/christophe-le-tourneau/"},{"id":"eliane-piaggio","kind":"person","name":"Eliane Piaggio","route":"/people/eliane-piaggio/"},{"id":"francois-clement-bidard","kind":"person","name":"François-Clément Bidard","route":"/people/francois-clement-bidard/"},{"id":"olivier-delattre","kind":"person","name":"Olivier Delattre","route":"/people/olivier-delattre/"},{"id":"sergio-roman-roman","kind":"person","name":"Sergio Roman-Roman","route":"/people/sergio-roman-roman/"},{"id":"steven-le-gouill","kind":"person","name":"Steven Le Gouill","route":"/people/steven-le-gouill/"},{"id":"sylvie-bonvalot","kind":"person","name":"Sylvie Bonvalot","route":"/people/sylvie-bonvalot/"}],"paper":[{"id":"paper-mlecnik-immunoscore-msi-colorectal-immunity-2016","kind":"paper","name":"Integrative analyses of colorectal cancer show Immunoscore is a stronger predictor of patient survival than microsatellite instability","route":"/key-papers/paper-mlecnik-immunoscore-msi-colorectal-immunity-2016/"},{"id":"paper-pages-immunoscore-international-validation-lancet-2018","kind":"paper","name":"International validation of the consensus Immunoscore for the classification of colon cancer","route":"/key-papers/paper-pages-immunoscore-international-validation-lancet-2018/"}],"pathway":[{"id":"tumor-microenvironment","kind":"pathway","name":"Tumour microenvironment (TME)","route":"/pathways/tumor-microenvironment/"}],"idea":[{"id":"idea-immune-exclusion-drivers","kind":"idea","name":"What actually holds T cells at the tumour border?","route":"/ideas/idea-immune-exclusion-drivers/"}],"institution":[{"id":"fondation-arc","kind":"institution","name":"Fondation ARC pour la recherche sur le cancer","route":"/institutions/fondation-arc/"},{"id":"has-france","kind":"institution","name":"Haute Autorité de Santé","route":"/institutions/has-france/"},{"id":"inca","kind":"institution","name":"Institut National du Cancer","route":"/institutions/inca/"},{"id":"institut-pasteur","kind":"institution","name":"Institut Pasteur","route":"/institutions/institut-pasteur/"}],"roadmap":[{"id":"radiation-roadmap","kind":"roadmap","name":"Radiotherapy roadmap: X-rays → shaped beams → fewer fractions, particles and FLASH","route":"/roadmaps/radiation-roadmap/"}],"company":[{"id":"lysa","kind":"company","name":"LYSA (The Lymphoma Study Association)","route":"/companies/lysa/"},{"id":"unicancer","kind":"company","name":"UNICANCER","route":"/companies/unicancer/"}]}}